About the Event
COPD affects more than 15 million Americans and worldwide is the third leading cause of death. Spire Health has been working with Stanford University, Brigham and Women’s Hospital, the NIH and 17 other healthcare organizations, creating an FDA-approved remote patient monitoring system that reduces hospitalizations for COPD by 65%. Their state-of-the-art wearable device monitors a COPD patient’s respiration while being completely unobtrusive and portable, leading to 94% compliance by the user.
Please join our webinar with Spire Health CEO, Mike Doyle where he’ll discuss real world results from over 3,400 patients and why their technology has attracted the interest of major health organizations such as Kaiser Permanente and Asaar Medical.